United Health Products, Inc. (UEEC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200K 400K 600K Q4 '10: 69.1K Q4 '13: 3.1K Q1 '14: 149.8K Q2 '14: 148.4K Q3 '14: 146.8K Q4 '14: 162.7K Q1 '15: 25.8K Q2 '15: 47.8K Q3 '15: 67.9K Q4 '15: 53.3K Q1 '16: 79.2K Q2 '16: 84.1K Q3 '16: 84.8K Q4 '16: 242K Q1 '17: 433.3K Q2 '17: 448.3K Q3 '17: 495K Q4 '19: 4.9K Q1 '20: 5.2K Q2 '20: 427 Q3 '20: 563 Q4 '20: 643 Q1 '21: 411 Q2 '21: 275 Q3 '21: 139 Q4 '21: 59 Q1 '22: 0 Q2 '22: 0 Q3 '22: 37.5K Q4 '22: 37.5K Q1 '23: 37.5K Q2 '23: 37.5K Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '13 Q2 '15 Q4 '16 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit TTM

-150K 0 150K 300K 450K Q4 '13: 3.1K Q1 '14: 106.6K Q2 '14: 105.2K Q3 '14: 103.6K Q4 '14: 79.7K Q1 '15: -19K Q2 '15: -9.5K Q3 '15: 597 Q4 '15: 25.8K Q1 '16: 35.6K Q2 '16: 38.7K Q3 '16: 35.5K Q4 '16: 124.1K Q1 '17: 321.1K Q2 '17: 329K Q3 '17: 368.5K Q4 '19: 3.6K Q1 '20: 3.8K Q2 '20: -548 Q3 '20: -446 Q4 '20: 448 Q1 '21: 296 Q2 '21: 216 Q3 '21: 114 Q4 '21: 34 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.9K Q4 '22: 18.9K Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '19 Q4 '20 Q4 '21 Q4 '22

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: -2.6M Q1 '11: -3.1M Q2 '11: -2.1M Q3 '11: -1.3M Q4 '11: -1.3M Q1 '12: -811K Q2 '12: -615.2K Q3 '12: -464.9K Q4 '12: -207K Q1 '13: -201.9K Q2 '13: -246K Q3 '13: -1M Q4 '13: -1.3M Q1 '14: -1.4M Q2 '14: -1.5M Q3 '14: -781.6K Q4 '14: -2.1M Q1 '15: -3.5M Q2 '15: -3.5M Q3 '15: -3.8M Q4 '15: -2.6M Q1 '16: -1.1M Q2 '16: -1M Q3 '16: -809.7K Q4 '16: -517.5K Q1 '17: -343.7K Q2 '17: -394K Q3 '17: -358.7K Q4 '17: -928.4K Q1 '18: -1.3M Q2 '18: -2.2M Q3 '18: -2.4M Q4 '18: -1.9M Q1 '19: -4.2M Q2 '19: -3.9M Q3 '19: -4M Q4 '19: -6.1M Q1 '20: -4.1M Q2 '20: -4.1M Q3 '20: -12.7M Q4 '20: -14.8M Q1 '21: -40.9M Q2 '21: -41.6M Q3 '21: -33.2M Q4 '21: -29.8M Q1 '22: -4M Q2 '22: -3.5M Q3 '22: -3.3M Q4 '22: -2.8M Q1 '23: -2.9M Q2 '23: -2.6M Q3 '23: -2.5M Q4 '23: -2.4M Q1 '24: -1.8M Q2 '24: -1.7M Q3 '24: -1.7M Q4 '24: -2M Q1 '25: -3.1M Q2 '25: -2.9M Q3 '25: -2.8M Q4 '25: -2.3M Q1 '26: -1M Q2 '26: -930.3K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: -2.9M Q1 '11: -3.5M Q2 '11: -2.3M Q3 '11: -1.5M Q4 '11: -1.6M Q1 '12: -1.1M Q2 '12: -902.6K Q3 '12: -750.7K Q4 '12: -281.4K Q1 '13: -270.7K Q2 '13: -315.8K Q3 '13: -847.4K Q4 '13: -1.1M Q1 '14: -1.2M Q2 '14: -1.3M Q3 '14: -851.7K Q4 '14: -2.1M Q1 '15: -3.5M Q2 '15: -3.5M Q3 '15: -3.8M Q4 '15: -2.6M Q1 '16: -1.1M Q2 '16: -1M Q3 '16: -818.4K Q4 '16: -535.7K Q1 '17: -365.9K Q2 '17: -424.1K Q3 '17: -390.8K Q4 '17: -1.5M Q1 '18: -5.5M Q2 '18: -6.3M Q3 '18: -6.6M Q4 '18: -5.4M Q1 '19: -4.1M Q2 '19: -4M Q3 '19: -4.1M Q4 '19: -6.6M Q1 '20: -4.6M Q2 '20: -4.5M Q3 '20: -13.1M Q4 '20: -15.7M Q1 '21: -42.1M Q2 '21: -42.7M Q3 '21: -34.2M Q4 '21: -30.5M Q1 '22: -4.5M Q2 '22: -4M Q3 '22: -2.5M Q4 '22: -1.7M Q1 '23: -1.9M Q2 '23: -1.5M Q3 '23: -2.8M Q4 '23: -2.6M Q1 '24: -1.9M Q2 '24: -1.8M Q3 '24: -1.7M Q4 '24: -2M Q1 '25: -3.1M Q2 '25: -3M Q3 '25: -3M Q4 '25: -2.7M Q1 '26: -1.5M Q2 '26: -1.4M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 35K 70K 105K Q2 '18: 41K Q3 '18: 23.2K Q4 '18: 96.7K Q1 '19: 87.8K Q2 '19: 86.5K Q3 '19: 83.1K Q4 '19: 1.3K Q1 '20: 1.4K Q2 '20: 975 Q3 '20: 1K Q4 '21: 25 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.6K Q4 '22: 18.6K Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '21 Q2 '22 Q4 '22

Operating Cash Flow TTM

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q3 '11: -416.2K Q4 '11: -284.3K Q1 '12: -194.8K Q2 '12: -123.9K Q3 '12: -21.1K Q4 '12: -2.2K Q1 '13: -631 Q2 '13: -38.6K Q3 '13: -38.2K Q4 '13: -118.8K Q1 '14: -168.6K Q2 '14: -256.1K Q3 '14: -369.6K Q4 '14: -334.8K Q1 '15: -580K Q2 '15: -565.5K Q3 '15: -655.4K Q4 '15: -844K Q1 '16: -676.1K Q2 '16: -591.6K Q3 '16: -547.4K Q4 '16: -473.4K Q1 '17: -439.4K Q2 '17: -464.7K Q3 '17: -456.1K Q4 '17: -649.7K Q1 '18: -874.9K Q2 '18: -1.1M Q3 '18: -1.3M Q4 '18: -1.3M Q1 '19: -1.2M Q2 '19: -1.5M Q3 '19: -1.6M Q4 '19: -1.8M Q1 '20: -2M Q2 '20: -1.8M Q3 '20: -1.7M Q4 '20: -1.3M Q1 '21: -932.9K Q2 '21: -685.1K Q3 '21: -603K Q4 '21: -828.1K Q1 '22: -913.3K Q2 '22: -963.7K Q3 '22: -771.7K Q4 '22: -619.7K Q1 '23: -972.1K Q2 '23: -1.2M Q3 '23: -1.8M Q4 '23: -2.2M Q1 '24: -2.1M Q2 '24: -1.9M Q3 '24: -1.6M Q4 '24: -1.2M Q1 '25: -1.1M Q2 '25: -959.9K Q3 '25: -815.3K Q4 '25: -1.2M Q1 '26: -997.3K Q2 '26: -950.6K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 100M 200M 300M Q3 '22: 279.7M Q1 '23: 233.3M Q2 '23: 238.3M Q3 '23: 241.5M Q1 '24: 245.8M Q2 '24: 247.7M Q3 '24: 248.6M Q1 '25: 254.6M Q2 '25: 257.1M Q3 '25: 257.8M Q1 '26: 258.7M Q2 '26: 260M Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.24 -0.16 -0.08 0.00 0.08 0.16 0.24 Q4 '10: -0.06 Q1 '11: -0.07 Q2 '11: -0.05 Q3 '11: -0.03 Q4 '11: -0.02 Q1 '12: -0.01 Q2 '12: -0.01 Q3 '12: -0.01 Q4 '12: 0.00 Q1 '13: 0.00 Q2 '13: 0.00 Q3 '13: 0.00 Q4 '13: -0.01 Q1 '14: -0.01 Q2 '14: -0.01 Q3 '14: -0.01 Q4 '14: -0.02 Q1 '15: -0.03 Q2 '15: -0.03 Q3 '15: -0.03 Q4 '15: -0.01 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.03 Q2 '18: -0.04 Q3 '18: -0.04 Q4 '18: -0.03 Q1 '19: -0.03 Q2 '19: -0.02 Q3 '19: -0.02 Q4 '19: -0.04 Q1 '20: -0.02 Q2 '20: -0.02 Q3 '20: -0.07 Q4 '20: -0.08 Q1 '21: -0.20 Q2 '21: -0.21 Q3 '21: -0.16 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.02 Q4 '25: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '11 Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.